0001213900-20-029901.txt : 20201002
0001213900-20-029901.hdr.sgml : 20201002
20201002160246
ACCESSION NUMBER: 0001213900-20-029901
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201002
DATE AS OF CHANGE: 20201002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASAMENTO CHARLES J
CENTRAL INDEX KEY: 0001117167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39082
FILM NUMBER: 201219908
MAIL ADDRESS:
STREET 1: 99 BELBROOK WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0306
4
2020-10-01
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001117167
CASAMENTO CHARLES J
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR
NEW YORK
NY
10022
1
0
0
0
Common Stock
2020-10-01
4
S
0
3000
37.9852
D
52173
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $37.04 to $38.58. The average weighted price was $37.9852. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Charles J. Casamento
2020-10-02